Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Comment on: Ketogenic diet treatment in recurrent diffuse intrinsic pontine glioma in children: A safety and feasibility study.

Perez A, Merlini L, El-Ayadi M, Korff C, Ansari M, von Bueren AO.

Pediatr Blood Cancer. 2019 Feb 15:e27664. doi: 10.1002/pbc.27664. [Epub ahead of print] No abstract available.

PMID:
30767367
2.

Ketogenic diet treatment in recurrent diffuse intrinsic pontine glioma in children: A safety and feasibility study.

van der Louw EJTM, Reddingius RE, Olieman JF, Neuteboom RF, Catsman-Berrevoets CE.

Pediatr Blood Cancer. 2019 Mar;66(3):e27561. doi: 10.1002/pbc.27561. Epub 2018 Nov 28.

PMID:
30484948
3.

Diffusion tensor imaging suggests extrapontine extension of pediatric diffuse intrinsic pontine gliomas.

Wagner MW, Bell WR, Kern J, Bosemani T, Mhlanga J, Carson KA, Cohen KJ, Raabe EH, Rodriguez F, Huisman TA, Poretti A.

Eur J Radiol. 2016 Apr;85(4):700-6. doi: 10.1016/j.ejrad.2016.02.004. Epub 2016 Feb 4.

4.

Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.

Hennika T, Becher OJ.

J Child Neurol. 2016 Oct;31(12):1377-85. doi: 10.1177/0883073815601495. Epub 2015 Sep 14. Review.

5.

Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.

Yamasaki F, Kurisu K, Kajiwara Y, Watanabe Y, Takayasu T, Akiyama Y, Saito T, Hanaya R, Sugiyama K.

Neuro Oncol. 2011 Jul;13(7):791-801. doi: 10.1093/neuonc/nor038. Epub 2011 Jun 8.

6.

Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma.

Huang TY, Piunti A, Lulla RR, Qi J, Horbinski CM, Tomita T, James CD, Shilatifard A, Saratsis AM.

Acta Neuropathol Commun. 2017 Apr 17;5(1):28. doi: 10.1186/s40478-017-0436-6.

7.

Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.

Sewing ACP, Lagerweij T, van Vuurden DG, Meel MH, Veringa SJE, Carcaboso AM, Gaillard PJ, Peter Vandertop W, Wesseling P, Noske D, Kaspers GJL, Hulleman E.

J Neurosurg Pediatr. 2017 May;19(5):518-530. doi: 10.3171/2016.9.PEDS16152. Epub 2017 Feb 17.

PMID:
28291423
9.

Diffuse intrinsic pontine gliomas: treatments and controversies.

Bredlau AL, Korones DN.

Adv Cancer Res. 2014;121:235-259. doi: 10.1016/B978-0-12-800249-0.00006-8. Review.

PMID:
24889533
10.

Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.

Carceller F, Fowkes LA, Khabra K, Moreno L, Saran F, Burford A, Mackay A, Jones DT, Hovestadt V, Marshall LV, Vaidya S, Mandeville H, Jerome N, Bridges LR, Laxton R, Al-Sarraj S, Pfister SM, Leach MO, Pearson AD, Jones C, Koh DM, Zacharoulis S.

J Neurooncol. 2016 Aug;129(1):109-21. doi: 10.1007/s11060-016-2151-8. Epub 2016 May 14.

PMID:
27180091
11.
12.

The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma.

Burzynski SR, Janicki TJ, Burzynski GS, Marszalek A.

Childs Nerv Syst. 2014 Dec;30(12):2051-61. doi: 10.1007/s00381-014-2401-z. Epub 2014 Apr 10.

15.

Conventional and Advanced Imaging of Diffuse Intrinsic Pontine Glioma.

Tisnado J, Young R, Peck KK, Haque S.

J Child Neurol. 2016 Oct;31(12):1386-93. doi: 10.1177/0883073816634855. Epub 2016 Apr 12. Review.

16.

Diffuse intrinsic brainstem tumors in neonates. Report of two cases.

Shah NC, Ray A, Bartels U, Rutka J, Bouffet E, Drake J, Hawkins CE, Huang A.

J Neurosurg Pediatr. 2008 May;1(5):382-5. doi: 10.3171/PED/2008/1/5/382.

PMID:
18447673
17.

A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.

Veldhuijzen van Zanten SE, Jansen MH, Sanchez Aliaga E, van Vuurden DG, Vandertop WP, Kaspers GJ.

Expert Rev Anticancer Ther. 2015 Feb;15(2):157-64. doi: 10.1586/14737140.2015.974563. Epub 2014 Nov 29.

PMID:
25435089
18.

A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth.

De Feyter HM, Behar KL, Rao JU, Madden-Hennessey K, Ip KL, Hyder F, Drewes LR, Geschwind JF, de Graaf RA, Rothman DL.

Neuro Oncol. 2016 Aug;18(8):1079-87. doi: 10.1093/neuonc/now088. Epub 2016 May 3.

19.

ERGO: a pilot study of ketogenic diet in recurrent glioblastoma.

Rieger J, Bähr O, Maurer GD, Hattingen E, Franz K, Brucker D, Walenta S, Kämmerer U, Coy JF, Weller M, Steinbach JP.

Int J Oncol. 2014 Jun;44(6):1843-52. doi: 10.3892/ijo.2014.2382. Epub 2014 Apr 11. Erratum in: Int J Oncol. 2014 Dec;45(6):2605.

20.

Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.

Klimo P Jr, Nesvick CL, Broniscer A, Orr BA, Choudhri AF.

J Neurosurg Pediatr. 2016 Jan;17(1):57-65. doi: 10.3171/2015.6.PEDS15166. Epub 2015 Oct 16.

PMID:
26474099

Supplemental Content

Support Center